SUFENTANIL CITRATE

Desflurane

Beijing Tiantan HospitalSmall moleculeN/AActive

D

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 95/ 100

Competitive context

5 Active assets in the Desflurane cohort.

Asset / Sponsor	Phase	Rating
Remimazolam Seoul National University Bundang Hospital	Phase 4	BB
Desflurane Beijing Tiantan Hospital	Phase 2	B
RAMIFENTANYL Beijing Tiantan Hospital	N/A	D
CISATRACURIUM ION Beijing Tiantan Hospital	N/A	D
PROPOFOL Beijing Tiantan Hospital	N/A	D

Same molecule, other indications

SUFENTANIL CITRATE is also rated in:

Anesthesia, LocalDormant

BBB

Indicative ·

73 / 100

Arrhythmia, CardiacDormant

BB

Indicative ·

69 / 100

Pain, AcuteDormant

BB

Indicative ·

69 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.